[31.03.2021] Nur wer Tumore im Detail versteht, kann sie optimal behandeln. Dr. Katharina Lückerath vom UK Essen erforscht, wie ihre biologischen Prozesse ablaufen. Die neue Professorin für Präklinische Nuklearmedizinische Theranostik entwickelt an der Medizinischen Fakultät der UDE neue Ansätze für Radionuklidtherapien und bildgebende Verfahren.

[8.03.2021] It is called the "survival protein" because it plays a central role in the growth of cancer cells: survivin influences two important processes in the body's cells at the same time – cell death and cell division. Chemists and biologists at the UDE have now succeeded in developing a precise molecule that can bind the protein’s surface at a defined site and switch it off. "Nature Communications" covers the topic.

[18.01.2021] One of the world's most important publications on COVID-19 was written in cooperation with the medical faculty and scientific partners in Wuhan (China). It was published in April 2020 and describes important changes in the immune system of those affected. Eight months later, the relevance of the study becomes apparent: It is one of the most cited publications on the subject worldwide.

[08.01.2021] Clinics and institutes of the University Hospital Essen that collect and analyze disease data and samples from COVID-19 patients are supported by the German Federal Ministry of Education and Research (BMBF) with 895,000€ until the end of this year. The joint goal of the researchers and clinicians is to formulate new research questions and answer existing ones.

[21.12.2020] In a study, researchers from the Faculty of Medicine are investigating the role played by certain immune cells in the fight against SARS-CoV-2 and why some of them last longer than others. Their findings could become particularly important for the treatment and vaccination of the population against COVID-19. The German Research Foundation (DFG) is funding the project for one year with 38,000 euros through a COVID-19 emergency program.

[03.12.2020] Researchers from the Medical Faculty of the UDE and the German Consortium for Translational Cancer Research (DKTK) at the partner location Essen/Düsseldorf have been able to explain a new mechanism in the human immune system. On the basis of their results, new approaches can be studied to improve the therapeutic success of blood stem cell transplants. The German-Dutch study was published in the renowned journal Blood.

[01.09.2020] SARS-CoV-2 viruses can be completely inactivated with ultraviolet light. This was shown of Virologyby a promising study by ZMB member PD Dr. Adalbert Krawczyk (photo) and Dr. Christiane Heilingloh from the Institute at the University Hospital Essen. The American Journal of Infection Control is now reporting on this. Their research was funded by the University Medicine Essen Foundation and the Rudolf Ackermann Foundation.

[10.06.2020] The DFG approved funding for an exciting new research project of Dr. Vikramjeet Singh that targets at exploring how the interaction with gut microbiota shapes the impact of neutrophils on ischemic brain injury. Singh is principal investigator at the Institute of Experimental Immunology and Imaging at the University Hospital Essen. Working as postdoc at the Institute for Stroke and Dementia Research at the LMU Medical Center, Singh and his colleagues identified a bidirectional communication along the brain–gut microbiota–immune axis and could show that the gut microbiota is a potentially central regulator of immune homeostasis.

[22.05.2020] Das menschliche Immunsystem reagiert auf mehr als nur das bisher fokussierte Virusprotein. Das ist bedeutend für Tests und mögliche Impfstoffe. Forschungsteams der Ruhr-Universität Bochum (RUB) und der Medizinischen Fakultät der UDE am Universitätsklinikums Essen haben herausgefunden, auf welche Teile des Sars-Cov-2-Virus das menschliche Immunsystem reagiert: Neben dem bisher fokussierten Spike-Protein können auch zwei weitere Proteine eine starke Immunantwort auslösen.